Toptan Müslüm
Department of Ophthalmology, Harran University Faculty of Medicine, Sanlıurfa, Türkiye.
J Curr Glaucoma Pract. 2025 Jan-Mar;19(1):50-54. doi: 10.5005/jp-journals-10078-1456. Epub 2025 Mar 24.
We aimed to compare the effects of trabeculotomy (AbE-TLO), gonioscopy-assisted transluminal trabeculotomy (GATT), and Ahmed glaucoma valve (AGV) implantation on intraocular pressure (IOP) and the number of antiglaucomatous medications used in pediatric aphakic glaucoma (AG).
Between 2017 and 2022, 27 eyes of 24 children who underwent AbE-TLO, GATT, and AGV in our clinic for pediatric AG were retrospectively analyzed. Corneal dimensions, corneal thickness, axial length, and surgical technique were recorded. Baseline and postoperative follow-up IOP measurements and antiglaucomatous drops used were analyzed.
AbE-TLO was performed in 37% ( = 9), GATT in 30% ( = 7), and AGV implantation in 33% ( = 8) of the patients included in our study. The mean follow-up period was 39.12 ± 3.19 months. In the 2nd postoperative year, IOP decreased significantly from 33.9 to 17.7 mm Hg with AbE-TLO ( = 0.014), from 34.3 to 18.3 mm Hg with GATT ( = 0.033), and from 34.5 to 16.4 mm Hg with AGV ( = 0.002). When all three surgical methods were compared, no significant difference was observed in IOP reduction at 1 and 2 years ( > 0.05). The number of antiglaucomatous medications decreased from 2.3 to 0.8 ( = 0.005) in AbE-TLO, from 2.4 to 0.5 ( = 0.008) in GATT, and from 2.3 to 0.6 ( = 0.005) in AGV at 2 years after surgery.
There was a significant decrease in IOP, along with a significant reduction in the usage of antiglaucomatous drugs, across all three primary surgical methods. No significant difference was detected regarding the reduction in IOP and the usage of antiglaucomatous medications.
Approximately, half of the patients with pediatric AG undergo surgery. However, the most appropriate surgical technique for AG remains unclear. Minimally invasive glaucoma surgeries, increasingly performed in recent years, now constitute a pivotal aspect of glaucoma surgical treatment. Thus, the main objective of the current research is to compare the impacts of AbE-TLO, GATT, and AGV implantation on IOP as the primary surgical method in pediatric AG.
Toptan M. Comparison of the Intraocular Pressure-lowering Effects of Three Primary Surgical Procedures in Pediatric Aphakic Glaucoma. J Curr Glaucoma Pract 2025;19(1):50-54.
我们旨在比较小梁切开术(AbE-TLO)、房角镜辅助小梁切开术(GATT)和艾哈迈德青光眼引流阀(AGV)植入术对小儿无晶状体性青光眼(AG)患者眼压(IOP)及抗青光眼药物使用数量的影响。
回顾性分析2017年至2022年间在我们诊所接受AbE-TLO、GATT和AGV治疗小儿AG的24例患儿的27只眼。记录角膜尺寸、角膜厚度、眼轴长度及手术技术。分析基线和术后随访的眼压测量值及使用的抗青光眼滴眼液。
在我们纳入研究的患者中,37%(n = 9)接受了AbE-TLO,30%(n = 7)接受了GATT,33%(n = 8)接受了AGV植入术。平均随访期为39.12±3.19个月。术后第2年,AbE-TLO组眼压从33.9显著降至17.7 mmHg(P = 0.014),GATT组从34.3降至18.3 mmHg(P = 0.033),AGV组从34.5降至16.4 mmHg(P = 0.002)。比较所有三种手术方法,1年和2年时眼压降低情况无显著差异(P>0.05)。术后2年,AbE-TLO组抗青光眼药物数量从2.3降至0.8(P = 0.005),GATT组从2.4降至0.5(P = 0.008),AGV组从2.3降至0.6(P = 0.005)。
所有三种主要手术方法均使眼压显著降低,同时抗青光眼药物使用量也显著减少。在眼压降低和抗青光眼药物使用方面未检测到显著差异。
小儿AG患者中约一半接受手术治疗。然而,AG最合适的手术技术仍不明确。近年来越来越多开展的微创青光眼手术现已成为青光眼手术治疗的关键方面。因此,本研究的主要目的是比较AbE-TLO、GATT和AGV植入术作为小儿AG主要手术方法对眼压的影响。
Toptan M. Comparison of the Intraocular Pressure-lowering Effects of Three Primary Surgical Procedures in Pediatric Aphakic Glaucoma. J Curr Glaucoma Pract 2025;19(1):50-54.